FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Notice on Complex Generic Meetings Guidance Corrected

[ Price : $8.95]

Federal Register notice: FDA corrects an 11/25 notice on a guidance entitled Formal Meetings Between the Food and Drug Administrat...

Comments on Bladder Cancer Drug Development Guidance

[ Price : $8.95]

Two drug companies comment on an FDA draft guidance on developing drugs and biologics for adjuvant treatment of bladder cancer.

Genus Seeks Court Order Against Lannetts Numbrino

[ Price : $8.95]

Genus asks a Maryland federal court to require FDA to withdraw its approval of Lannett Numbrino because Lannett made materially un...

Kessler, Sharfstein in the Running for FDA Top Post

[ Price : $8.95]

FDA watchers speculate that former commissioner David Kessler and former principal deputy commissioner Joshua Sharfstein are top c...

FDA Renews Pharmacy Compounding Advisory Panel

[ Price : $8.95]

Federal Register notice: FDA renews its Pharmacy Compounding Advisory Committee for an additional two years.

Groups Ask Agency, Research Funding

[ Price : $8.95]

Some 76 healthcare organizations call on congressional leaders to approve increased funding for FDA and other key health agencies ...

FDA Covid Test EUA Priorities Updated

[ Price : $8.95]

FDA updates Covid test FAQs with an explanation of current agency priorities for reviewing test EUA requests.

MPM Medical Recalls Contaminated Regenecare Hydrogel Lot

[ Price : $8.95]

FDA says MPM Medical has recalled one lot of Regenecare HA Hydrogel due to bacterial contamination.

Former CBER Reviewer Joins NDA Partners

[ Price : $8.95]

Former CBER investigator and reviewer John Godshalk joins NDA Partners as an expert consultant.

Viveve Gains Clearance to Increase Manufacturing

[ Price : $8.95]

FDA clears a Viveve Medical 510(k) to expand its manufacturing capacity for its consumable treatment tips used with the companys C...